Clinical Director, Assistant Professor of Medicine Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Harvard Medical School Boston, Massachusetts
Learning Objectives:
Identify R/R MM management strategies, incorporating novel therapeutic targets to overcome the challenges of therapeutic resistance, AEs, and tolerability